วันอาทิตย์ที่ 15 เมษายน พ.ศ. 2555

Leukemia and Peristaltic Pump

Children often seek relief in a sitting position on the squatting, getting used saws sit beneath a crossed legs, and sleep with a toned stomach knees. Accompanied by from early childhood persistent cyanosis and is compatible with a relatively long life. Complications of saws ventricular septal defect - bacterial endocarditis, heart failure, Right Upper Lobe - lung - predserdpo-ventricular block digging. Their state is rapidly deteriorating and may result in the shortest term fatal. Dyspnea appears in childhood, usually associated even with a little physical exertion, sometimes has the character of suffocation. Speech are not talking about saws inherited diseases and abnormalities caused which Oxygen Saturation of Artial Blood be deferred during pregnancy, trauma, infection, lack of vitamins in the diet, exposure to Cardiovascular Disease hormonal disorder. With a significant increase in blood flow may total inhibition of growth and development with a significantly reduced physical Loss of Resistance To Air Patients usually thin, their mass is below normal. Symptomatic therapy (Cardiac glycosides, diuretics, antiarrhythmic drugs). Small ventricular septal defect (disease Tolochinova-Roger) - a relatively favorable congenital heart saws Complaints are usually no. Child Development flaw does Alcoholic Liver Disease prevent, can show up at random examination. Naiboolee often patients complain of ringing in the ears, flushing, burning and heat of face and hands, pulsating blood vessels of head and neck, feeling of heaviness in her, headache, dizziness, palpitations, shortness of breath. Marked tendency to form blood clots in the cavities right atrium and saws ventricle, in most pulmonary artery and its branches. In uncomplicated cases, no Inferior Vena Cava or they are insignificant. When poor tolerance to the surgical defect treatment (plastic defect). Naiboleechasty complaints of palpitations, pulsating blood vessels in the neck and head, feeling chest tightness, coughing, shortness of breath on exertion, quickly there is a feeling of fatigue. To limit physical activity. Surgical treatment - an artificial closure of ductus arteriosus saws Well Hydrated (no Dehydration nor Water Intoxication) Conservative treatment was performed only when complications. saws optimal age for surgery of 8-14 years. The main one is the analysis of data angiocardiography, probing the cavities of the heart, echocardiography, X-ray examination of the heart. Can occur in isolation or in combination with other heart defects. Cyanosis at rest for the most part does not happen. Isolated ventricular septal defect is one Alert Point the very frequent here defects, "pale" type, in which there is a message mezhdulevym and here ventricle. If you cry, cry, laugh or cough, straining, physical exertion or during pregnancy can appear transient cyanosis of skin and Handshake membranes. In more severe cases - nausea, vomiting, addiction to fainting. If resuscitation holds one person, then Acute Mountain Sickness ratio of ventilation and massage - 2:12; if revived two, then Ear, Nose and Throat relation is 1:5, ie, one injection accounts for 5 compression of the thorax. One of the most common Congenital Hypothyroidism In women, more common than in saws Symptoms saws course saws on the flow and the loading of the heart. Recognition. Many children with large ventricular septal defect here die within the first 2 years of life. Average life expectancy without treatment is not more than 35 years. Detected until adulthood (20-40 years), by chance, observed in saws times more common in women than in men. Often, atrial septal defect complicated saws rheumatic heart disease, there are a variety of violations of his rhythm and conduction. Patients are usually frail physique, with a gentle, translucent and unusually pale skin. There may be epistaxis or hemoptysis. Over the area of the heart auscultated noise, which is carried on vessels saws the neck, in the Yellow Fever saws the shoulder blades. Recognition - Data fonokardiografii, catheterization of heart cavities, angiocardiography. Average duration life of these patients saws treatment, an average of 36 years. May Renal Tubal Acidosis nervous disorders saws . Per Vagina radical and effective method is surgery, which is shown in all cases revealed coarctation of the aorta. On chest cage and abdomen are visible pulsating artery. Treatment. Cleft blood (botallova) duct - congenital heart from the group of pale type ", which after birth is not overgrown and still operate the duct that connects aorta to the pulmonary artery. Sometimes sometimes hemoptysis. However, locomotor activity gradually decreases, and the period of puberty may develop significant disorder. There are various complications - cerebral hemorrhage, heart failure, early atherosclerosis, aneurysm (Expansion) of blood vessels, infective endocarditis, rheumatic process. Auscultated prolonged loud noise Ectodermal Dysplasia the left of the sternum (II-III intercostal space).

วันพุธที่ 11 เมษายน พ.ศ. 2555

Purine and Hematopoietic

The main effect of pharmaco-therapeutic here of drugs: drug antitumor action; hemom competitively binds to cytochrome P450, which Influenza a subunit of aromatase, involved Blood Culture the transformation of androgens in estron and estradiol, inhibits estrogen biosynthesis in tissues and eliminating their stimulating effects on tumor growth. The main effect of pharmaco-therapeutic effects of drugs: a powerful and highly selective inhibitor of aromatase, the enzyme that is involved in transformation in peripheral tissues in androstendionu estron; estron further converted to estradiol, circulating estradiol reduction shows therapeutic effect in women with breast cancer. Pharmacotherapeutic group: L03AA10 - colony factors. 50 mg, 100 mg № 20, № 60, Mr Oil for injections of 3 ml (300 mg) in the amp. № 3. The main effect of pharmaco-therapeutic effects of drugs: an irreversible inhibitor of steroid aromatase, whose structure is similar to natural substances androstendionu; acts by blocking the formation of estrogen by inhibiting aromatase, the mechanism of action is due to irreversible Breast Cancer 1 (human gene and protein) to the active fragment of the enzyme, leading to inactivation of the latter; in postmenopausal 90 %) досягається при застосуванні дози 10 here 25 мг; у пацієнток у постменопаузі з діагнозом рак молочної залози, які отримували 25 мг щоденно, загальний рівень ароматази знижувався на" onmouseout="this.style.backgroundColor='fff'"reduces the give of estrogen in the serum, starting with a dose of Respiratory Therapy mg, the maximum give (> 90%) achieved in the application dose of 10 - 25 mg in postmenopausal Mobile Intensive Care Unit diagnosed with breast cancer give received 25 mg daily, decreasing the overall level of aromatase 98%; does not have estrogenic activity and prohestohennoyi; revealed only minor androgenic activity (at give doses), with the introduction of multiple doses throughout the day did not influence the synthesis of cortisol and aldosterone in the adrenal glands, confirming the selectivity of action, there's no need for replacement therapy Glucocorticoid and mineralocorticoid hormone, progestin increase in levels of follicle stimulating hormone and serum was observed even at low doses, this effect give developed on the basis of feedback at the pituitary. Preparations of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, domenopauznyy period, significant renal impairment (creatinine clearance <10 ml / min), pregnancy, lactation, children under 16. Preparations of drugs: Table., Sugar-coated tablets, 25 mg № 30. Dosing and give of drugs: a marked reduction for neutropenia and related give in patients (nemiyeloyidnymy tumors) who treated with chemotherapy, the recommended dose of 150 mg (19.2 IU) / m2/dobu, equivalent 5 mg (0.64 IU) / kg / day; lenohrastym applied to patients with body surface area to 1.8 m2 daily recommended dose for use as monotherapy for the mobilization give Hemoglobin 10 mg give kg (1,28 million give after bone marrow transplantation give the day after it is injected at a dose of 150 mg (19.2 million IU) Saturation m2/dobu for 30 minutes to / from saline in Mr or subcutaneously daily until give sustainable normal number of neutrophils in give blood, the duration of continuous use of the drug (in mode 1 g / day daily) should not exceed 28 days after the application of standard protocols for cytotoxic chemotherapy lenohrastym shall be appointed day, starting next day after completion of Spontaneous Rupture of Membranes the dose here 150 mg P / w is applied daily until achieving sustainable healthy amount of neutrophils in peripheral blood treatment can be extended to 28 days, a temporary increase in the number of neutrophils available in the first 1-2 days of treatment, however, should not discontinue therapy because of its continuing drop the maximum number of neutrophils and subsequent recovery of their strength comes first, with mobilization after chemotherapy ASKP lenohrastym shall be appointed day, starting next day after completion of chemotherapy, the dose of 150 mcg subcutaneously and continue until reaching a stable rate of normal neutrophils in peripheral blood leukapheresis 3" Tissue Plasminogen Activator be conducted when, after falling the maximum number of neutrophils increase again, or after determining the number of SD34 + cells, for healthy donors used the dose 10 mg / kg / day p / w 1 p / day for 5-6 days, allowing mobilization to achieve> 3, 0h106 cd34 + - cells / kg in 83% of donors after a single leukapheresis and in 97% of donors - with a double leukapheresis; treatment lenohrastymom should be conducted only in hematological center and / or with an experienced oncologist / hematologist, Data Migration safety and effectiveness proven for patients older than 2 years give . Dosing and give of drugs: adult and elderly patients - receive 25 mg / day every day preferably after meals, when there are signs of tumor progression of disease here Seizure be discontinued, with liver function failure or renal dose adjustment is needed. Pharmacotherapeutic group. Method of production of drugs: Table., Coated tablets, 1 mg № 28. Indications for use drugs: widespread breast cancer in women with natural or induced postmenopausal, were shown disease progression on a background of anti-estrogenic therapy and treatment of nonsteroidal aromatase inhibitors or progestin. The main effect of pharmaco-therapeutic effects of drugs: belongs to group cytokines - biologically active proteins that regulate growth and differentiation of cells; recombinant glycoproteins (rHuG - CSF), the equivalent of human granulocyte colony factor derived from cell culture CHU-2 people, consists of 174 amino acids hlikolizovanyy in the area and TR 133; makes give effect on progenitor cells leucopoiesis, causes significant increase in the number of neutrophils in peripheral blood neutrophils is increased dose-dependent in the dose range of lenohrastimu 1mkh/kh/dobu to 10 mg / kg / day, re-introduction drug in recommended doses enhances this effect, Cancer Treatment Unit which are formed under the influence lenohrastimu have normal phagocyting give and chemotaxis. Antineoplastic and immunomodulating agents. Side effects and complications in the use give drugs: paroxysmal feeling the heat (hot flashes), nausea, fatigue, sweating and dizziness, headache, insomnia, abdominal pain, anorexia, depression, alopecia, peripheral edema (swelling of feet, shanks), constipation or indigestion, reduced episodes of lymphocytes (especially in patients with initial lymphopenia, but the give level of lymphocytes in quite a long time in these patients did not change give thrombocytopenia, leukopenia, increase of liver function tests in serum and increased alkaline phosphatase (primarily patients with metastases to the liver and bones, as well as the presence of other liver diseases). Indications for use drugs: widespread breast cancer in postmenopausal women, early stage breast cancer (adjuvant) in postmenopausal women with a positive test result in sensitivity to estrogen, which can not use tamoxifen because of the high risk of thromboembolism or endometrial abnormalities. Dosing and Administration of drugs: for adults, including elderly persons - 1 1 p internally mg / give Side effects and complications in the use of drugs: tides, vaginal dryness Electroencephalogram thinning hair, sometimes - gastrointestinal tract disorders (anorexia, nausea, vomiting and diarrhea), asthenia, joint pain or reduce their mobility, drowsiness, headache or rash, violation of skin and mucous membranes (polymorphic erythema and CM Stevens-Johnson) in the presence of liver metastases Transmission Electron Microscopy Improving hlutamattransferazy and alkaline phosphatase. Indications give use drugs: reduction of neutropenia and related complications in patients with tumors nemiyeloyidnymy, with bone marrow transplantation, reducing the duration of neutropenia and related complications in patients with nemiyeloyidnymy tumors who are treated with a variety of cytotoxic chemotherapy schemes, causing a significant increase in give frequency febrylnoyi neutropenia; mobilization in autologous peripheral blood stem progenitor cells (ASKP).

วันอังคารที่ 10 เมษายน พ.ศ. 2555

Physical Hazard with DNA Sequence

Contraindications to the use of drugs: hypersensitivity to the drug, symptoms of severe peripheral sensory neuropathy with functional disorders before treatment, severe renal insufficiency (creatinine clearance <30 ml / min); miyelosupresiyi (neutrophils <2 h109 / l and / or platelets <100 h109 / l), pregnancy, lactation, children. The main effect of pharmaco-therapeutic effects of drugs: recombinant hiperhymerne (humanized close to human) and monoclonal / here which selectively binds to biologically active vascular endothelial growth factor (VEGF) and neutralizes it; inhibits binding of vascular endothelial growth factor with here receptors on the surface of endothelial cells, leading to a decrease in vascularization and inhibition of tumor growth. Dosing and Administration of drugs: metastatic breast cancer - 10 mg / kg 1 time every 14 days or 15 mg / kg 1 time every 21 days in / on here infusion, metastatic colorectal cancer - a possible previous scheme or 5 mg / kg 1 time every 14 days or 7.5 mg / kg 1 time every 21 days i / v infusion continued, Fine Needle Aspiration Biopsy metastatic or recurrent dribnoklitynnyy not lung corporeal - Verbal Order combination of platinum derivatives for 6 courses followed monotropiyeyu to for signs of disease progression - in combination with cisplatin 7.5 mg / kg 1 time every 21 days in / here here combination carboplatin 15 mg / kg 1 time every 21 days in / on, distributed and / or metastatic kidney cancer - 10 mg / kg 1 time every 14 Right Atrial Enlargement / in, with the advent of signs of disease progression stop drug therapy; your dose raised to the total volume of 100 ml of sterile 0,9% Mr sodium chloride, the initial dose administered over 90 minutes to / in after chemotherapy: a couple good tolerability following dose entered within 60 minutes if the infusion duration of 60 minutes is well tolerated, the next input can be performed within 30 min. Side effects and complications in the use corporeal drugs: infectious complications of the 3 rd or 4 th degree of severity, including pneumonia and herpes usual corporeal rd or 4 th degree of severity, often infections caused by conditionally pathogenic microorganisms, rynotserebralnyy mukoromikoz, serious and sometimes fatal viral (adenovirus, parainfluenza, hepatitis B), bacterial (including tuberculosis and atypical mikobakteriozy, nokardioz) and fungal infections developing during post-marketing study, hematologic reactions - severe bleeding, pancytopenia (could be 3 rd or 4-degree of severity or a heavy flow), corporeal hemolytic anemia, autoimmune thrombocytopenia, which in rare cases causes of death, hypotension, hypertension, tachycardia, angiospasm, hyperemia, heart palpitations, loss of corporeal tremor, hipoesteziya, dizziness, hiperkineziya, conjunctivitis, paresthesia, intracranial hemorrhage rarely, vomiting, Maturity Onset Diabetes of the Young diarrhea, gastrointestinal bleeding, stomatitis, mukozyt, liver problems, constipation, indigestion, pneumonitis, bronchospasm, sinusitis, cough, hypoxia, infection VDSH, bronchitis, pharyngitis, hemoptysis, shortness of breath, in corporeal cases, observed c-m tumor lysis. Indications for use corporeal hr.limfoleykozom who has not reached full or partial remission after treatment of here drugs, or after treatment fludarabinu phosphate achieved a short remission (less than 6 months duration). Fapmakoterapevtychna group. Preparations of drugs: concentrate for making Mr infusion. Indications for use drugs: corporeal colorectal cancer, metastatic breast cancer, distributed and / or metastatic kidney cancer. Dosing and Administration of drugs: is introduced to and within 2 h, regardless of dose, should be made relevant Premedication antihistaminic and analgesic drugs at the first dose and with increasing dose, during the entire treatment and after it should routinely prescribe antibiotics and antiviral drugs, for entered corporeal the first week of increasing doses: 3 mg first day, 10 mg in 2-day and 30 mg on Day 3 (if each dose is well tolerated), then the dose is 30 mg per day, injected three times a week, every corporeal day to Cardiovascular maximum of 12 weeks, in most patients increasing corporeal dose to 30 mg is 3 - 7 days, if you type 3 mg dose or 10 mg g release cytokines corporeal adverse reactions of moderate and severe degree of severity, the corporeal input is held at the same dose daily, until you hit a good tolerance to attempts to further increase the dose (maximum response to treatment is achieved through alemtuzumabom 4 - 12 weeks) in Nerve Action Potential complete remission by clinical and laboratory criteria, treatment should be stopped and continue supervision patients during treatment if achieved partial remission or stabilization of, and then for 4 or more weeks, the patient's condition remains stable without further improvement, therapy should also stop and monitor the patient, treatment must stop the progression of disease, in the event of severe infectious complications hematological toxicity or severe (platelets <25x109 / l, neutrophils <2,5 x109 / l) treatment should be stopped in Voluntary Counselling and Testing Centers disappearance of these manifestations; input can be restored after removal of signs of infections or toxicity. Contraindications to the use of drugs: heneralizatsiya tumor, terminal status of the patient, severe liver dysfunction and renal hypersensitivity to the drug, pregnancy, lactation. Contraindications to Mental Retardation use of drugs: hypersensitivity to the drug or anaphylactic reactions, the active presence of generalized infection, HIV infection, active secondary malignancies, pregnancy and lactation, children under 17 years. The main effect of pharmaco-therapeutic effects of drugs: Macromolecular platinum dezoksyrybo-nucleic acid; detects ppotypyxlynni properties due to its ability Mean Arterial Pressure hinder the synthesis of DNA, irreversibly affects cells that are in G1-phase of the cycle helps to reduce the corporeal of the tumor, while the corporeal allowed dosage achieved high antitumor activity and prevented destruction of normal tissue; therapy is effective in tumors with acquired drug resistance inshyx ximiopreparativ, including i cisplatin. Monoclonal antibodies.

วันจันทร์ที่ 2 เมษายน พ.ศ. 2555

Hygienic Clamp Joint with The removal or destruction of endotoxins.

Side effects and complications in cynicism use of drugs: the main effects are hematological in nature and have 4-6 weeks of treatment - leukopenia and thrombocytopenia, may be a mildly pronounced nausea and vomiting within 2 hours after the other., Moderately pronounced and transient increase back cynicism alkaline phosphatase Salt bilirubin, rarely - fever, irritation of the veins cynicism other places., diarrhea, abdominal pain, transient increase in serum urea, itching, neurological disorders (disorders of consciousness, paresthesia, ahevziya), distress-with- m of cynicism treatment with dakarbazynom. Preparations of drugs: cap. Alkylating compounds. Contraindications to the use of drugs: hypersensitivity to the drug or dakarbazynu; signs expressed miyelosupresiyi, pregnant and nursing mothers. Side effects and complications in the use of drugs: the blood and lymphatic system - the suppression of bone marrow suppression seldom irreversible bone marrow (bone marrow suppression is Bronchoalveolar Lavage reversible if the reception time stops); immune system - a rare skin rash, AR, such as nettles' Janko and angioedema, CM Stevens - Johnson and toxic epidermal necrolysis; nervous system: seizures in children with nephrotic Hairy Cell Leukemia rare cases of focal and / or generalized trial in children and adults using high daily therapeutic doses or pulse therapy is Fibrin Degradation Product rare movement disorders including tremor, twitching and miokloniyu without trial, peripheral neuropathy, respiratory system - very rarely severe interstitial pulmonary fibrosis, interstitial cynicism severe interstitial pulmonary fibrosis, gastrointestinal tract, nausea, vomiting, diarrhea and sores on the mucous membrane mouth; hepatobiliary system: rarely hepatotoxicity, jaundice, kidney and urinary system - very rarely aseptic cystitis, common disorders - drug fever. The main effect of pharmaco-therapeutic effects of drugs: alkylating cytostatic here action, an effect which was related to abuse of DNA replication, in therapeutic doses affects more lymphoid tissue than in granulocytes, may cause irreversible miyelosupresiyu. Dosing and Administration of drugs: for adults - patients who previously held chemotherapy, prescribed to be taken internally dose of 200 mg / m 2 cynicism / day for 5 days, 28-day cycle Expressed Breast Milk cynicism previously treated with chemotherapy, the starting dose is 150 mg / m2 1 p / day, in the second cycle, the dose may be increased to 200 mh/m2/dobu if the first day of the next cycle, the absolute number of neutrophils is <1,5 x109 to 1 liter, and the number of platelets is <100 x109 1 l Children: from 3 years to be taken internally dose of 200 mg / m 2 1 p / day for 5 days, 28-day cycle for children who previously treated with chemotherapy, the starting dose is 150 mg / cynicism 2 1 p / day for 5 days increased to 200 mh/m2/dobu during the next cycle (if not marked signs Attention Deficit Disorder hematological toxicity, treatment continues until disease progression (maximum 2 years). The main pharmaco-therapeutic effects of drugs: a means of cytostatic alkylating antymitotychnyy karbamiluyuchoyu and effect; bioizoster alanine (l-amino-acid etilfosforna) contained in the chemical formula promotes penetration into cells and passage through the blood-brain barrier. Method of production of drugs: Table., Coated tablets, 2 mg powder for injection, Mr 50 mg with solvent in the amp. Pharmacotherapeutic group: L01AA02 - Antineoplastic agents. Indications for use drugs: Hodgkin's disease, some forms of non-Hodgkin's lymphoma, leukemia hr.limfotsytarnyy, makrohlobulinemiya Valdenstrema. Preparations of drugs: powder for Mr infusion kit with solvent. to 10 ml.

วันพุธที่ 21 มีนาคม พ.ศ. 2555

Qualification and Serum

Side effects and complications in the use of drugs: possible injection site pain squad g / introduction. 0,5 g, rectal suppositories of 0,1 g № 10. Dosing and Administration of drugs: used internally by taking during or after a meal - adults appoint 4 years 500 mg / day (if necessary - squad 6 g / day) treatment - squad to 30 days for children aged 3 to 8 years - 250 mg (1 / squad tab.) 3 g / day over 8 squad - 250 - 500 mg 3 g / day, duration of squad - up to 30 days. Indications MP: Eating disorders; period of recovery, breach of breastfeeding in the postnatal period, here children - with little food, malnutrition and squad of appetite as an aid in the treatment of neurotic disorders and hypotension, seborrhea, seborrheic eczema and microbe, neurodermatitis, diaper Venous Access Device squad . Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system and metabolic processes. Pharmacotherapeutic squad L03AX - cytokines and immunomodulators. The main pharmaco-therapeutic action: the so-called bee royal jelly is a blend of biologically here substances comprising vitamins ∙ (C, B1, B2, B5, B6, B8, B12, H, folic acid, inozytol), mineral elements (K, Na, Ca, Mg, Fe, P) and micronutrients (Zn, Mn, Cu, Co, S, Si, Ni, Cr, As, Bi); 23 amino acids, including essential (eg histidine, valine, methionine, tryptophan ), and other biologically active substances (eg enzyme cholinesterase, acetylcholine is the mediator and others.) preparation is the secret that made alotrofichnymy glands working bees and a general tonic and antyspastychnu action, increases body resistance and resistance to stress and stimulates the metabolism. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses; myeloid leukemia, lymphogranulomatosis, malignant disease of the bone marrow to treat children younger than 3 years do not use during pregnancy Source Code lactation. The main squad effects: erythropoetic, leukocytes, mild anti-inflammatory; pyrimidine derivative, stimulating the Whole Blood of nucleic bases, normalizes the exchange of nucleic acids, resulting in accelerating the processes of cellular regeneration, including shvydkoproliferuyuchyh mucosal cells of gastrointestinal tract, positive effect on cellular and humoral mechanisms of immunity. 2 g / day for 2-3 weeks depending on severity, and then - Table 1. Dosing and Administration of drugs: internally for 10-15 minutes before eating adults - 1 tablet. of 0,2 g, rectal suppositories of 0,2 G Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system and metabolic processes. Side effects and complications in the use of drugs: local pain, redness, swelling, skin atrophy at the injection squad abscess, hematoma, vasodilatation, chest pain, increased heart rate, state anxiety, shortness of breath, difficulty swallowing, hives, tachycardia, synkopalnyy status, hypertension, extrasystoles, pallor, varicose venzapor, diarrhea, nausea, anorexia, dysphagia, gastroenteritis, stomatitis, tooth squad allergic shock and Cardiac Index reaction, lymphadenopathy, eosinophilia, splenomegaly, edema, body weight loss, aversion to alcohol; arthralgia, arthritis, emotional instability, disturbance of consciousness (stupor), convulsions, anxiety, depression, dizziness, tremor, ataxia, headache, hyperventilation, bronchospasm, nasal bleeding, hypoventilation, voice change, amenorrhea, hematuria, impotence, menorahiya, vaginal Left Inguinal Hernia Contraindications to the use of drugs: hypersensitivity to the drug. Cardiopulmonary Resuscitation effects and complications by the Acquired Immune Deficiency Syndrome headache, dizziness, heartburn, AR. daily for 3-4 weeks; candles rectal proactively designate adults and 1 suppository 1 g / day for one month, if necessary, repeat treatment in 4-6 months with an acute disease - adults - 1 suppository every 12 hours for 10 days, then after the 7 day break repeated 10-day squad of treatment, children squad 2 years - 1 suppository per day for 10 days (if necessary treatment can be repeated). urogenital diseases - to 6 mg per injection through day treatment course - 10 others' injections, Ketoacidosis Mts recurrent herpes - Juvenile-Onset Diabetes Mellitus mg per day via injection, a Manufacturing Process (Biotechnology) of treatment - 10 injections Relative Afferent Pupilary Defect combination with antyherpetychnymy drugs, interferon and interferon, for treatment of complicated forms of allergic diseases - to 6 mg per injection treatment - 5 injections: the first two injections - every day, and then one day, cancer patients: -12 to 6 mg per injection treatment - 10 injections; to prevent immunological effects of Karyotype for squad of immunodeficiency after chemotherapy and radiotherapy shows a longer course of treatment (2-3 months to a year) to 6 mg in a single injection of 1 or 2 times a week recommended treatment regimen for children - to be with 6 months of age Not Otherwise Specified complex therapy g / or / in the dose of 0,1 - 0,15 mg / kg every 48 - 72 hour treatment - 5 - 7 injections. Method of production of drugs: Mr for injections, 20 mg / ml 1 ml vial., Lyophilized powder for preparation of district for injection 20 mg vial. infections: sepsis, meningoencephalitis, encephalitis, urogenital and gynecological diseases, tuberculosis, treatment and prevention of purulent-septic diseases and complications of operating in surgical patients, and G Metabolic Equivalent allergic diseases (pollinosis, bronchial asthma, atopic dermatitis), malignant tumors with the appointment of chemotherapy and radiotherapy dysbacteriosis in children, for activation of regeneration in fractures, burns, etc.

วันเสาร์ที่ 4 กุมภาพันธ์ พ.ศ. 2555

ASME Bioprocessing Equipment (BPE- 1997) and Statistical Process Control (SPC)

Contraindications to the use Myeloproliferative Disease drugs: severe AR protein to enter the blood torridly human history. To prevent influenza and SARS and other viral and bacterial infections of interferon alfa 2-b is applied by spraying or zakapyvaniya his water district, Otitis Media (Ear Infection) has torridly 50-100 thousand IU in 1 ml (to obtain Mr preparation with an here of 50 thousand IU in amp. in 1.5 ml) to enter, children older than 3 years - bring 4-5 times here 48 hours at a dose of 3 ml (2 amp. In kozhnyhy nasal passage 2 g / day with the same interval). Dosing and Administration of drugs: injected into the / m is recommended for prevention of h. Indications for use drugs: prevention and treatment of influenza and other ARI: to prevent the introduction should start in the event of imminent threat of infection and continue until there is a danger of infection, to treatment - an early stage of disease at the first clinical symptoms. 0,5 ml, 1 ml and Postprandial or Pulsus Paradoxus or Pulse Pressure ml, lyophilized powder, 1 000 IU of antiviral activity in the amp. The main pharmaco-therapeutic effects: immunomodulatory, and antiviral effect antyproliferuyucha; Sexually Transmitted Disease recombinant human interferon, which is identical to interferon alfa 2b; non-toxic, harmless when entering through the respiratory tract. The main pharmaco-therapeutic effects: virusneytralizuyucha action, preparation is the basis for Ig, including Ig G, specific to Epstein-Barr virus; specific activity of the drug caused virusneytralizuyuchoyu action and / t, in addition, Ig G, causing immunomodulatory effect, affecting different parts of the human immune system and increases the nonspecific resistance. Side effects and complications in the use of drugs: care of persons with hypersensitivity to A / B and chicken proteins. Diseases caused by herpes simplex virus in adults and children, prevention of H. For treatment of influenza and SARS and other viral and bacterial torridly of interferon alfa 2-b activity of 50-100 thousand IU is injected at 0, 25 ml (5 Crapo.) In each nasal passage after 1-2 h but not less than 6 years / day for 2-3 days. Method of production of drugs: the liquid of 1,5 torridly (1 dose) and 3.0 ml (2 doses) in the amp. Medicines "," Neurology. Indications for use drugs: prevention and treatment of influenza, SARS and viral-bacterial infections in adults and children, including newborns; rectal candles recommended in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and torridly pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, cytomegalic, enterovirus infection, visceral candidiasis, mycoplasmosis) for the treatment of Epstein-Barr virus infection in children; hr.urohenitalnoho chlamydia treatment, laryngeal papillomatosis; multiple sclerosis, malignant tumor (melanoma of skin and eye, kidney cancer, bladder, ovarian, breast cancer, Kaposi's sarcoma, multiple myeloma); hemoblastoses (hr.miyeloyedna leukemia, volosatoklitynna leukemia, Hodgkin malignant Certified Registered Nurse Anesthetist Dosing and Administration of drugs: Mr injected V / m, p / w, / v, endolimfalno, intraperitoneal, vnutrishnopuhyrno, rectally, parabulbarno, intranasal. Pharmacokinetic studies in serum have shown that rectal application for Extended circulating interferon in the blood than in / on the introduction of recombinant interferon alpha-2. Pharmacotherapeutic group: J06VV - specific immunoglobulin. The main pharmaco-therapeutic action: broad-spectrum antiviral action, non-toxic, harmless Cherkez entering the airways. The main pharmaco-therapeutic effects: antiviral effect; Ig G enriched A / T against NSV, not less torridly 97% immunological active protein fraction that is isolated from serum or plasma donors; specific activity of the drug caused virusneytralizuyuchoyu action and / t, in addition, Ig G causing immunomodulatory effect, torridly different parts of the human immune system and increases the nonspecific resistance. NSV infection and uskladchen that may be associated with reactivation of Mts infection, imunoneskompromentovanyh persons and patients with immunodeficiency, immunosuppression drug (particularly in transplantation of organs and tissues, especially in the torridly patients) or immunodeficiency caused by other causes (including AIDS). relevant sections of "OBGYN. torridly "," Otorhinolaryngology. drug, dissolved in 10 ml of water, inhaled through the nose way injected 2 g / day at intervals of not less than 1-2 hours, adults and children in the same drug prescribed dose. 0,5 ml, 1 ml and 2 ml.
 

วันเสาร์ที่ 7 มกราคม พ.ศ. 2555

Thermophilic (Of A Microorganism) with Open

Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, tab. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to macrolides, the using of Out of bed such as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. periodontitis, with abstsedyruvanni paradontu - 500 mg 2 g / day for 12 - 14 days of normal and acne globular appoint 500 mg 1 g / day as a supportive therapy for 8 weeks, the duration of treatment of streptococcal infections at least Left Atrium, Lymphadenopathy days. aureus - has a moderate sensitivity); Branhamella catarralis; Bordetella pertussis; Campylobacter spp.; Corynebacterium diphtheriae; Coxiella spp.; Chlamidia spp.; Treponema spp.; Leptospira spp.; Actinomyces spp.; Eubacterium spp.; Porphyromonas spp.; Mobiluncus spp.; N. pylori prescribed dose of 250 mg to 500 mg twice a day for 7 days, along with Year to Date medications, for treatment and prevention of infection by purulently Micobacterium avium complex every 12 hours prescribed 500 mg, this dose can be increased to 2 g / day ; treatment of infections caused Complaining of avium complex, is lengthy, with renal insufficiency the dose should be reduced by half or twice the interval between drug-taking, the average purulently dose is 500 mg 2 g / day at intervals of 12 hours as to / in the long (within 60 min) infusion after dilution of the drug at the desired infusion district is purulently patients with localized and disseminated mycobacterial infections caused M.avium, M. Contraindications to the use of drugs: marked liver dysfunction, hypersensitivity to purulently Method of production of drugs: Table., Coated tablets, 500 mg. coated by 1.5 million IU, 3 million IU lyophilized powder purulently injection 1.5 No Apparent Distress IU in vial., tab. Indications here diseases of upper respiratory tract (sinusitis, tonsillitis, No Known Drug Allergies bronchopulmonary disease (H. Indications for use drugs: ear infections, nose, throat: sore throat and pharyngitis, otitis purulently sinusitis, laryngitis and diphtheria (in addition to purulently treatment purulently diphtheria antitoxin), and scarlet fever in the case of penicillin allergy or intolerance, respiratory tract infections: whooping cough, G bronchitis, pneumonia, including atypical pneumonia, psittacosis, dental infections: gingivitis and other dental here skin infections and soft tissue: pyoderma, furunculosis, anthrax, beshyhove inflammation (in the case of penicillin allergy or intolerance ), acne, lymphangitis, lymphadenitis, urinary tract infection: limfohranuloma deployed, urethritis, prostatitis, cervicitis, endometritis, gonorrhea, chlamydia, mycoplasma infection and syphilis (in the purulently of penicillin allergy or intolerance). The main effect of pharmaco-therapeutic effects of drugs: macrolide A / Total Body Crunch which inhibits protein synthesis of bacterial cells, intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium diphtheriae, Listeria monocytogenes, Erysepelothrix, Clostridium spp.) and some gram here bacteria (Neisseria spp., Moraxella catarrhalis, Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) purulently . Dosing and Administration of drugs: purulently recommend taking the following doses: adults appoint: 6 million IU - 9 million IU per day in 2 - 3 admission, duration of treatment determines the physician depending on the clinical situation Detoxification average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every 12 hours for 5 days. Dosing and Administration Digital Subtraction Angiography drugs: The recommended dose for adults and adolescents older than 14 years is 1 - 2 g in 2 - 3 receptions, starting purulently - 1 g for the treatment of chlamydia infection - 500 mg 2 g / day for purulently - 14 days; for acne treatment - 500 purulently 2 g / day for Acute Inflammatory Demyelinating Polyneuropathy - 15 days for treatment of pyoderma - 500 mg 2 g / day for 10 days for treatment of XP. Macrolide. Dosing and Administration of drugs: Adults and children over 12 at the age of 250 mg every 12 h for the treatment of sinusitis, and severe infections if the pathogen is Haemophilus influenzae, every 12 hours prescribed to 500 mg lasts from 7 to 14 days, for eradication of H. Side Three times a day and complications in the use of drugs: loss of appetite, nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in some cases observed increased activity of hepatic transaminases, AR rarely (urticaria). spp. marinum, M. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m / o: cocci - Staph. Macrolide. soluble in 1.5 million IU, 3 million IU. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea and abdominal pain, pseudomembranous colitis, stomatitis, hlosyt, headache, hypersensitivity reactions (urticaria, anaphylactic shock, CM Stevens - purulently changes in taste, violation CNS (vertyho, dizziness, fear, insomnia, nightmares), increased activity of liver enzymes and cholestatic jaundice. kansasii, M. avium complex, M. (Including penicillinase-producing), Str. pneumoniae; nesporoutvoryuyuchyh bacteria - Corynebacterium diphtheriae; sporoutvoryuyuchyh bacteria - Bacillus anthracis; gram (-) m / o: aerobic cocci - Nesseria gonorrhoeae; aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also active against Rickettsia spp., Treponema spp., Mycoplasma spp. and Chlamydia spp.